...
机译:低肿瘤内调节性T细胞和高扰动CD8(+)T细胞涉及胰腺切除术后胰腺导管腺癌患者的长期存活
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Fudan Univ Inst Gen Surg Shanghai 200032 Peoples R China;
Fudan Univ Dept Gen Surg Zhongshan Hosp Shanghai 200032 Peoples R China;
Pancreatic ductal adenocarcinoma; Pancreatectomy; Tumor microenvironment; Tregs; CD8(+) T cells; Prognosis;
机译:肿瘤切除后低肿瘤内调节性T细胞和高肿瘤周围CD8(+)T细胞与胰腺导管腺癌患者的长期生存有关
机译:胰管腺癌胰腺切除术后的长期生存期(5-20年):从3个机构中收集了30例患者。
机译:胰导管腺癌全胰切除术和肠系膜上-门静脉切除术后的长期生存:一例报告
机译:纹理分析对胰腺癌新辅助化疗患者生存率的预测
机译:MMP-7调节正常胰腺腺泡细胞向与胰腺导管腺癌的肿瘤上皮相关的化生导管的过渡
机译:胰导管腺癌全胰切除术和肠系膜上-门静脉切除术后的长期生存:一例报告
机译:表8.4.C.1胰腺切割端缘(PCM)癌细胞的浸润表8.4.C.2胰腺切除术和PCM的程序表8.4.C.3胆汁管道切口癌细胞浸润边缘(BCM)表8.4.c.4在解剖胰腺组织边缘(DPM)下癌细胞浸润表8.4.c.5胰腺切除术和DPM的程序表8.4.c.6残留的肿瘤表8.4 .c.7胰腺切除术和残留肿瘤的程序图8.4.c.8根据胰蛋白酶切除末端边缘(PCM)的癌细胞渗透后,胰腺切除术后的患者存活患者图8.4.c.9根据残留胰腺组织边缘的癌细胞渗透(DPM)渗透后,胰腺切除术后的患者存活患者图8.4.c.10根据残留肿瘤,胰腺切除术后的内分泌肿瘤患者存活